Clinical Trials Logo

Chronic Daily Headache clinical trials

View clinical trials related to Chronic Daily Headache.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05306899 Recruiting - Clinical trials for Chronic Daily Headache

Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches

KetHead
Start date: June 1, 2022
Phase: Phase 3
Study type: Interventional

Chronic daily headaches (CDH) poses a significant burden on patients, healthcare systems and the society. Intravenous (IV) ketamine infusion, an intervention that is widely available and scalable, can treat CDH by reversing receptor-mediated sensitization. This study is a multicenter, placebo-controlled, parallel group randomized trial with blinding of participants and observers with the goal of comprehensively assessing the effect of high-dose IV ketamine infusion (1 mg.kg-1.h-1 for six hours) on the frequency and intensity of headaches, mood, activity, sleep, quality of life and safety of ketamine for three months after the interventions. Use of validated questionnaires, wearable technology, a research team that includes investigators with expertise in studying ketamine and in evaluating treatments for CDH and pain syndromes are some of the unique features of this project. Our study aims to prospectively assess the efficacy and safety of high-dose intravenous ketamine infusions compared to saline infusions in participants with CDH syndrome.

NCT ID: NCT03231241 Recruiting - Chronic Migraine Clinical Trials

Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

Start date: December 12, 2014
Phase:
Study type: Observational

Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help explain this process.